KLF5 and cardiovascular disorder: Additionally, the abundances of Proteobacteria, which have been shown to be related to an increased risk of cardiovascular disease (26) and also to be associated with TMA production (27), and Gammaproteobacteria, which also have a relationship with TMA production (28), were increased in HF rats administered a KLF5 inhibitor.